ArticleAdvances in biomarker sciences and technology2025

Urine PD-L1 as a non-invasive biomarker for immune checkpoint inhibitor (ICI) therapy in bladder cancer.

Qianyun Ge et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.